• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对同源定向修复(HDR)和非同源末端连接(NHEJ)的系统定量揭示了基因座、核酸酶和细胞类型对基因组编辑的影响。

Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.

作者信息

Miyaoka Yuichiro, Berman Jennifer R, Cooper Samantha B, Mayerl Steven J, Chan Amanda H, Zhang Bin, Karlin-Neumann George A, Conklin Bruce R

机构信息

Gladstone Institute of Cardiovascular Disease, San Francisco, California, 94158, USA.

Digital Biology Center, Bio-Rad Laboratories, Pleasanton, California, 94588, USA.

出版信息

Sci Rep. 2016 Mar 31;6:23549. doi: 10.1038/srep23549.

DOI:10.1038/srep23549
PMID:27030102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4814844/
Abstract

Precise genome-editing relies on the repair of sequence-specific nuclease-induced DNA nicking or double-strand breaks (DSBs) by homology-directed repair (HDR). However, nonhomologous end-joining (NHEJ), an error-prone repair, acts concurrently, reducing the rate of high-fidelity edits. The identification of genome-editing conditions that favor HDR over NHEJ has been hindered by the lack of a simple method to measure HDR and NHEJ directly and simultaneously at endogenous loci. To overcome this challenge, we developed a novel, rapid, digital PCR-based assay that can simultaneously detect one HDR or NHEJ event out of 1,000 copies of the genome. Using this assay, we systematically monitored genome-editing outcomes of CRISPR-associated protein 9 (Cas9), Cas9 nickases, catalytically dead Cas9 fused to FokI, and transcription activator-like effector nuclease at three disease-associated endogenous gene loci in HEK293T cells, HeLa cells, and human induced pluripotent stem cells. Although it is widely thought that NHEJ generally occurs more often than HDR, we found that more HDR than NHEJ was induced under multiple conditions. Surprisingly, the HDR/NHEJ ratios were highly dependent on gene locus, nuclease platform, and cell type. The new assay system, and our findings based on it, will enable mechanistic studies of genome-editing and help improve genome-editing technology.

摘要

精确的基因组编辑依赖于通过同源定向修复(HDR)修复序列特异性核酸酶诱导的DNA切口或双链断裂(DSB)。然而,易错的非同源末端连接(NHEJ)同时起作用,降低了高保真编辑的效率。由于缺乏一种在内源基因座直接同时测量HDR和NHEJ的简单方法,有利于HDR而非NHEJ的基因组编辑条件的鉴定受到了阻碍。为了克服这一挑战,我们开发了一种基于数字PCR的新型快速检测方法,该方法可以在1000份基因组拷贝中同时检测到一个HDR或NHEJ事件。使用该检测方法,我们系统地监测了CRISPR相关蛋白9(Cas9)、Cas9切口酶、与FokI融合的催化失活Cas9以及转录激活样效应核酸酶在HEK293T细胞、HeLa细胞和人诱导多能干细胞中三个疾病相关内源基因座的基因组编辑结果。尽管人们普遍认为NHEJ通常比HDR更常发生,但我们发现在多种条件下诱导的HDR多于NHEJ。令人惊讶的是,HDR/NHEJ比率高度依赖于基因座、核酸酶平台和细胞类型。新的检测系统以及我们基于此的发现将有助于进行基因组编辑的机制研究,并有助于改进基因组编辑技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/50fd29ba8bed/srep23549-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/8eb295ed037f/srep23549-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/9e55eb05f217/srep23549-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/ef73dd941964/srep23549-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/49dc1ada1762/srep23549-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/30b8710f6d75/srep23549-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/50fd29ba8bed/srep23549-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/8eb295ed037f/srep23549-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/9e55eb05f217/srep23549-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/ef73dd941964/srep23549-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/49dc1ada1762/srep23549-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/30b8710f6d75/srep23549-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/4814844/50fd29ba8bed/srep23549-f6.jpg

相似文献

1
Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.对同源定向修复(HDR)和非同源末端连接(NHEJ)的系统定量揭示了基因座、核酸酶和细胞类型对基因组编辑的影响。
Sci Rep. 2016 Mar 31;6:23549. doi: 10.1038/srep23549.
2
Non-Homologous End Joining and Homology Directed DNA Repair Frequency of Double-Stranded Breaks Introduced by Genome Editing Reagents.基因组编辑试剂引入的双链断裂的非同源末端连接和同源定向DNA修复频率
PLoS One. 2017 Jan 17;12(1):e0169931. doi: 10.1371/journal.pone.0169931. eCollection 2017.
3
Detection and Quantification of HDR and NHEJ Induced by Genome Editing at Endogenous Gene Loci Using Droplet Digital PCR.使用液滴数字PCR检测和定量内源基因位点基因组编辑诱导的同源重组修复和非同源末端连接
Methods Mol Biol. 2018;1768:349-362. doi: 10.1007/978-1-4939-7778-9_20.
4
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.促进同源定向修复选择的方法以应对 CRISPR/Cas9 诱导的双链断裂。
Int J Mol Sci. 2020 Sep 4;21(18):6461. doi: 10.3390/ijms21186461.
5
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.CRISPR-Cas9 融合到显性失活 53BP1 中可特异性增强 HDR 并抑制 NHEJ 在 Cas9 靶位点处。
Nat Commun. 2019 Jun 28;10(1):2866. doi: 10.1038/s41467-019-10735-7.
6
Gene Editing With TALEN and CRISPR/Cas in Rice.利用TALEN和CRISPR/Cas对水稻进行基因编辑
Prog Mol Biol Transl Sci. 2017;149:81-98. doi: 10.1016/bs.pmbts.2017.04.006. Epub 2017 May 24.
7
Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing.RAD52 和 dn53BP1 的异位表达可提高 CRISPR-Cas9 基因组编辑过程中的同源定向修复。
Nat Biomed Eng. 2017 Nov;1(11):878-888. doi: 10.1038/s41551-017-0145-2. Epub 2017 Oct 9.
8
Modulating DNA Repair Pathways to Improve Precision Genome Engineering.调控 DNA 修复途径以提高精确基因组工程。
ACS Chem Biol. 2018 Feb 16;13(2):389-396. doi: 10.1021/acschembio.7b00777. Epub 2017 Dec 20.
9
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair.成簇规律间隔短回文重复序列(CRISPR)/CRISPR 相关蛋白 9 与改进的校对功能增强同源定向修复。
Nucleic Acids Res. 2018 May 18;46(9):4677-4688. doi: 10.1093/nar/gky264.
10
Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.组蛋白去乙酰化酶抑制剂增强 CRISPR/Cas9 介导的同源定向 DNA 修复。
Int J Biochem Cell Biol. 2020 Aug;125:105790. doi: 10.1016/j.biocel.2020.105790. Epub 2020 Jun 10.

引用本文的文献

1
Extracellular Vesicle-Mediated Delivery of Genetic Material for Transformation and CRISPR/Cas9-based Gene Editing in .用于转化和基于CRISPR/Cas9的基因编辑的细胞外囊泡介导的遗传物质递送
bioRxiv. 2025 Jun 17:2025.06.17.660080. doi: 10.1101/2025.06.17.660080.
2
Induced Pluripotent Stem Cells for the Treatment of Lysosomal Storage Disorders.诱导多能干细胞用于溶酶体贮积症的治疗
J Inherit Metab Dis. 2025 Jul;48(4):e70064. doi: 10.1002/jimd.70064.
3
Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management.

本文引用的文献

1
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA.利用不对称供体 DNA 增强具有催化活性和非活性的 CRISPR-Cas9 的同源定向基因组编辑。
Nat Biotechnol. 2016 Mar;34(3):339-44. doi: 10.1038/nbt.3481. Epub 2016 Jan 20.
2
Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.Cpf1是2类CRISPR-Cas系统中的一种单RNA引导的内切核酸酶。
Cell. 2015 Oct 22;163(3):759-71. doi: 10.1016/j.cell.2015.09.038. Epub 2015 Sep 25.
3
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.
用于脊柱疼痛管理的CRISPR基因组编辑治疗应用进展
Neurospine. 2025 Jun;22(2):421-440. doi: 10.14245/ns.2550462.231. Epub 2025 Jun 30.
4
A Molecular Glue Approach to Control the Half-Life of CRISPR-Based Technologies.一种控制基于CRISPR技术半衰期的分子胶水方法。
J Am Chem Soc. 2025 Jul 9;147(27):23844-23856. doi: 10.1021/jacs.5c06230. Epub 2025 Jun 30.
5
Progress in skin gene therapy: From the inside and out.皮肤基因治疗的进展:由内而外
Mol Ther. 2025 May 7;33(5):2065-2081. doi: 10.1016/j.ymthe.2025.03.017. Epub 2025 Mar 12.
6
Gene Editing for Enhanced Swine Production: Current Advances and Prospects.用于提高猪生产性能的基因编辑:当前进展与前景
Animals (Basel). 2025 Feb 3;15(3):422. doi: 10.3390/ani15030422.
7
Promotion or inhibition? This is a question in gene editing.促进还是抑制?这是基因编辑中的一个问题。
Mol Ther. 2025 Feb 5;33(2):444-446. doi: 10.1016/j.ymthe.2025.01.014. Epub 2025 Jan 21.
8
A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer.一种用于针对KRAS突变型肺癌进行CRISPR-Cas9肿瘤靶向递送的新型胶束复合物。
Nanoscale. 2025 Mar 13;17(11):6604-6619. doi: 10.1039/d4nr03471f.
9
Anionic polymer coating for enhanced delivery of Cas9 mRNA and sgRNA nanoplexes.用于增强Cas9 mRNA和sgRNA纳米复合物递送的阴离子聚合物涂层
Biomater Sci. 2025 Jan 28;13(3):659-676. doi: 10.1039/d4bm01290a.
10
-targeted, stable expression of ChR2 in human brain organoids for consistent optogenetic control.在人脑类器官中实现ChR2的靶向稳定表达,以进行一致的光遗传学控制。
Bioeng Transl Med. 2024 Jun 9;9(6):e10690. doi: 10.1002/btm2.10690. eCollection 2024 Nov.
新型转录激活样效应因子核酸酶(TALEN)的mRNA转染有助于高效敲除HIV共受体CCR5。
Nucleic Acids Res. 2015 Jun 23;43(11):5560-71. doi: 10.1093/nar/gkv469. Epub 2015 May 11.
4
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.利用整合酶缺陷型慢病毒载体无偏检测 CRISPR-Cas9 和 TALENs 的脱靶切割。
Nat Biotechnol. 2015 Feb;33(2):175-8. doi: 10.1038/nbt.3127. Epub 2015 Jan 19.
5
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.GUIDE-seq可实现对CRISPR-Cas核酸酶脱靶切割的全基因组分析。
Nat Biotechnol. 2015 Feb;33(2):187-197. doi: 10.1038/nbt.3117. Epub 2014 Dec 16.
6
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases.工程核酸酶诱导的DNA双链断裂的全基因组检测
Nat Biotechnol. 2015 Feb;33(2):179-86. doi: 10.1038/nbt.3101. Epub 2014 Dec 15.
7
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.通过控制CRISPR/Cas9递送时间实现增强的同源定向人类基因组工程。
Elife. 2014 Dec 15;3:e04766. doi: 10.7554/eLife.04766.
8
Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.靶向基因校正对人类疾病特异性诱导多能干细胞克隆中的全基因组突变负荷影响极小。
Cell Stem Cell. 2014 Jul 3;15(1):31-6. doi: 10.1016/j.stem.2014.06.016.
9
Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.通过全基因组测序检测到,单个CRISPR-Cas9和TALEN靶向的人类干细胞克隆中脱靶突变的发生率较低。
Cell Stem Cell. 2014 Jul 3;15(1):27-30. doi: 10.1016/j.stem.2014.04.020.
10
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.全基因组测序分析揭示了CRISPR/Cas9和基于TALEN的基因组编辑在人诱导多能干细胞中的高特异性。
Cell Stem Cell. 2014 Jul 3;15(1):12-3. doi: 10.1016/j.stem.2014.06.011.